FULC — Fulcrum Therapeutics Share News
0.000.00%
Last trade - 00:00- $253.21m
- -$80.11m
U.S. STOCKS ON THE MOVE-Fulcrum, iQIYI, MINISO
Fulcrum jumps as US FDA lifts hold on sickle cell disease therapy
Fulcrum Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Fulcrum Therapeutics Appoints Chief Financial Officer
Brief: Fulcrum Therapeutics Q2 Basic EPS USD -0.38
U.S. STOCKS ON THE MOVE-Hecla Mining, Shineco, Fulcrum Therapeutics
Brief: Fulcrum Therapeutics Signs Exclusive Global License Agreement In Rare Hematology
U.S. RESEARCH ROUNDUP-Albemarle, Ellington Financial, Savara
Fulcrum Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Fulcrum Therapeutics Announces Financial Results For The First Quarter 2023
Brief: Fulcrum Therapeutics Appoints Alex C. Sapir Chief Executive Officer
Fulcrum Therapeutics Inc expected to post a loss of 46 cents a share - Earnings Preview
Fulcrum Therapeutics Inc expected to post a loss of 46 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Allete, Gilead Sciences, Arcutis
Fulcrum falls as finance head to step down
Brief: Fulcrum Therapeutics Says Intends To Conduct Executive Search For Chief Financial Officer
Brief: Fulcrum Therapeutics Announces CFO Resignation
Brief: Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- Ameresco, Bioxcel Therapeutics, Roblox